Not Yet Recruiting
Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer
NCT07059949
- Conditions
- CAPOX, Combination of Radioimmunotherapy, Unresectable Metastatic Rectal Cancer
- Locations
-
Not specified